Erratum: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study) (Am J Gastroenterol (2023) DOI: 10.14309/ajg.0000000000002203)

RETRACT-B study group

Research output: Contribution to journalComment/debate

Abstract

In the originally published article, the average incidence rates of 0.41 per 1,000 person-years among the total cohort and 0.26 per 1,000 person-years among the subgroup in the Results section on page 4 were incorrectly reported as per 1,000 person-years, whereas the units should have been per 1,000 person-months. These errors do not affect the main results or conclusions of the paper. These corrections do not affect the description, interpretation, and conclusions of the manuscript. The authors apologize for this mistake.

Original languageEnglish
Pages (from-to)2145
Number of pages1
JournalAmerican Journal of Gastroenterology
Volume119
Issue number10
DOIs
StatePublished - 01 10 2024

Bibliographical note

Publisher Copyright:
© 2024 by The American College of Gastroenterology.

Keywords

  • Humans
  • Hepatitis B, Chronic/drug therapy
  • Antiviral Agents/therapeutic use
  • Incidence
  • Liver Failure/epidemiology
  • Withholding Treatment
  • Nucleosides/therapeutic use

Fingerprint

Dive into the research topics of 'Erratum: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study) (Am J Gastroenterol (2023) DOI: 10.14309/ajg.0000000000002203)'. Together they form a unique fingerprint.

Cite this